MACROD2 and breast carcinoma: This is particularly evident in breast cancer, where MACROD2 and FHIT are deleted in 28% and 15% of breast cancer cell lines, respectively, but either not at all (FHIT) or in only one out of 255 primary tumors (MACROD2) (Table S5).